Co-Founder of TBI Innovations to develop and commercialize innovative technology discovered by David W. Smith, M.D., CEO of TBII. The technology, named SLOSH Theory, led to a license agreement now incorporating numerous patents, which protect inventions derived from SLOSH Theory. Referred to internally as the Q-collar™, the first and highly prominent invention for protection from brain damage due to shock-trauma to the head (often called concussions) has been launched in Canada while our licensee works with the USFDA to coordinate the pivotal study anticipating market launch in 2019.

Mr. Kosterman has been starting new companies and working as an independent turnaround specialist for troubled assets since 1992. He has been involved in over a dozen startup and turnaround situations, including three as a principal. His most recent turnaround assignment, as President, was for a publicly traded medical company, where he stopped losses and put the company back on a profitable track in two quarters.

He was a Vice President for significant operations of Pfizer, CR Bard, and Smith & Nephew. In his corporate career he variously held positions in sales, marketing, product development, and general management, as well as strategist, especially related to acquisitions, and the Wall Street contact for the US subsidiary of a UK company.

He started new divisions within corporate America (Intrepreneur) and had several major successes in growing sales and profits through both new product programs and rehabilitating mature products and businesses with a new look and feel. As a consultant, Mr. Kosterman has been involved beyond medical and pharmaceutical products, as well. He has developed specialized training programs and delivered same throughout his career.

Mr. Kosterman’s marketing and business development successes have typically occurred through closely integrating them with the development of new or improved products. At Pfizer, Mr. Kosterman was the architect of an innovative database-marketing program (22% response rate with 76% retention) used successfully with colostomy product users in their homes. Mr. Kosterman graduated from the University of Wisconsin-Madison in with a degree in Finance, Investments and Banking.